SOFIE is Awarded $5M from Three Major SBIR Grants
CULVER CITY, Calif., Oct. 5, 2018 — Today SOFIE, an emerging theranostics company focused on […]
Acquisition of Zevacor Pharma Complete
September 27th 2017 Culver City, CA – Sofie Biosciences, Inc., the molecular imaging company specializing […]
SOFIE to Acquire Zevacor Pharma
Thursday, May 11, 2017 Sofie Biosciences, Inc., (Culver City, CA) announced today that it has […]
SOFIE receives $1.5M NCI Phase II SBIR
Original post: http://goo.gl/Li4BGt CULVER CITY, Calif., Oct. 16, 2014 /PRNewswire/ — SOFIE […]
SOFIE Receives $1.8M Phase II SBIR Grant
CULVER CITY, CA., October 2nd, 2013 – SOFIE BIOSCIENCES, an emerging in vivo imaging […]
SOFIE Receives $1M Phase II SBIR Grant
CULVER CITY, Calif., July 11, 2012 — Sofie Biosciences, Inc., a molecular imaging company offering […]
SOFIE Receives Phase I SBIR Grant
CULVER CITY, CA., April 24th, 2012 – Sofie Biosciences, Inc., a molecular imaging company offering […]
SOFIE Awarded a US patent on a Family of Novel PET Probes
CULVER CITY, CA., January 11, 2012 – Sofie Biosciences, Inc., offering a comprehensive range of […]
SOFIE is Awarded a DOE Phase II SBIR
CULVER CITY, CA., July 7th, 2011 – Sofie Biosciences, developer of molecular imaging systems and […]
SOFIE Raises $2M
CULVER CITY, CA, Tuesday, December 7th, 2010 – Sofie Biosciences, a developer of agents and […]